Stock listing
Kyorin Pharmaceutical Co.,ltd.
Selected listing: KYRNF · OTC · USD · US
Kyorin Pharmaceutical Co.,ltd. (OTC:KYRNF), Health Technology. Latest release Sep 30, 2026: (Update on Disclosed Matter) Notice Regarding Transfer of Generic…
- Ticker
- OTC:KYRNF
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- OTC
- Currency
- USD
Latest news from Kyorin Pharmaceutical Co.,ltd.
(Update on Disclosed Matter) Notice Regarding Transfer of Generic Drug Business
September 30, 2026
KYORIN to Commence Promotion Activities for Allergic Conjunctivitis Treatment Alesion Eyelid Cream 0.5%
August 3, 2026
[Summary]Consolidated Financial Results for the Three Months Ended June 30, 2026 [Japanese GAAP]
July 30, 2026
KYORIN Entered into Joint Marketing Agreement in Japan for Allergic Conjunctivitis Treatment Alesion Eyelid Cream 0.5%
July 13, 2026
KYORIN Pharmaceutical: Operating profit fell 71.6% year-over-year as sales declined and R&D costs rose
May 12, 2026
Research Kyorin Pharmaceutical Co.,ltd.
Kyorin Pharmaceutical Co.,ltd. company profile
View the public company page for Kyorin Pharmaceutical Co.,ltd. on 6ix.
Kyorin Pharmaceutical Co.,ltd. news
Read company news and market updates connected to Kyorin Pharmaceutical Co.,ltd..
Kyorin Pharmaceutical Co.,ltd. investor events
Find investor webinars, events, and replay context for Kyorin Pharmaceutical Co.,ltd..